The following pages link to Xianshu Wang (Q73864709):
Displaying 50 items.
- Genome-wide association studies identify four ER negative-specific breast cancer risk loci (Q24622610) (← links)
- Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome (Q24647329) (← links)
- Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk (Q27008356) (← links)
- DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein (Q28249796) (← links)
- Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers (Q28269064) (← links)
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (Q29416989) (← links)
- Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer (Q29417100) (← links)
- Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (Q31082788) (← links)
- Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies (Q33593016) (← links)
- Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus (Q33641475) (← links)
- Common genetic variants and modification of penetrance of BRCA2-associated breast cancer (Q33742096) (← links)
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival (Q33828680) (← links)
- Exploring the link between MORF4L1 and risk of breast cancer (Q33863235) (← links)
- Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers (Q33947829) (← links)
- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer (Q34081324) (← links)
- Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls (Q34123806) (← links)
- Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer (Q34181322) (← links)
- Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers (Q34213403) (← links)
- Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (Q34327945) (← links)
- Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade (Q34378972) (← links)
- Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (Q34379032) (← links)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction (Q34394665) (← links)
- MicroRNA related polymorphisms and breast cancer risk (Q34497352) (← links)
- Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells (Q34581742) (← links)
- Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers (Q34613604) (← links)
- Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer (Q34809698) (← links)
- Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers (Q34949394) (← links)
- Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers (Q34963894) (← links)
- Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium (Q34979715) (← links)
- Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer (Q34996647) (← links)
- Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers (Q35022825) (← links)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies (Q35022847) (← links)
- A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population (Q35089479) (← links)
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk (Q35102646) (← links)
- Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer (Q35104068) (← links)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium (Q35119701) (← links)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (Q35179897) (← links)
- Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers (Q35242849) (← links)
- Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (Q35382206) (← links)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (Q35523236) (← links)
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium (Q35532898) (← links)
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer (Q35541663) (← links)
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). (Q35622910) (← links)
- Association of breast cancer susceptibility variants with risk of pancreatic cancer (Q35640794) (← links)
- Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (Q35737888) (← links)
- A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer (Q35755874) (← links)
- Common variation in Nemo-like kinase is associated with risk of ovarian cancer (Q35815383) (← links)
- Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers (Q35870067) (← links)
- 19p13.1 is a triple-negative-specific breast cancer susceptibility locus (Q35871567) (← links)
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. (Q35889575) (← links)